Concepedia

Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial

Jonathan M. Spergel, Marc E. Rothenberg, Margaret H. Collins, Glenn T. Furuta, Jonathan E. Markowitz, George J. Fuchs, Molly O’Gorman, J. Pablo Abonia, James B. Young, Timothy Henkel,

Journal of Allergy and Clinical Immunology · 2011 · 551 citations · 16 references

DOI

Concepts

References

16

A Simple Sequentially Rejective Multiple Test Procedure

Sture Holm · Scandinavian Journal of Statistics · 1979 · 21.8K citations

, , +8

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial

Alex Straumann, Sébastien Conus, Pascale Grzonka et al. · Gut · 2009 · 589 citations · Full text

, , +16

A Randomized, Double-Blind, Placebo-Controlled Trial of Fluticasone Propionate for Pediatric Eosinophilic Esophagitis

Michael R. Konikoff, Richard J. Noel, Carine Blanchard et al. · Gastroenterology · 2006 · 583 citations · Full text

, , +16

Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab

Marc E. Rothenberg, Amy D. Klion, Florence Roufosse et al. · New England Journal of Medicine · 2008 · 575 citations · Full text

, , +7

Effect of SCH55700, a Humanized Anti-Human Interleukin-5 Antibody, in Severe Persistent Asthma: A Pilot Study

Johan Kips, Brian O’Connor, Stephen J. Langley et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 497 citations

, , +15